Product Description:

BML is Lunching Apalunix 60 mg tablet which is an androgen receptor inhibitor indicated for the treatment of patients with

  • Metastatic castration-sensitive prostate cancer
  • Non-metastatic castration resistant prostate cancer.

Apalunix  works by blocking the effects of androgen (a male reproductive hormone) to stop the growth and spread of cancer cells.

Product Features:

Product Name Apalunix
Generic Name Apalutamide INN
Formulation Tablet
Available Pack Size 120’s pot
Available Strength 60 mg
Registrations Available